skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Metformin and insulin receptors

Journal Article · · Diabetes Care; (United States)
OSTI ID:6223513

The authors evaluated the effect of metformin (N,N-dimethylbiguanide), a biguanide known to be less toxic than phenformin, on insulin binding to its receptors, both in vitro and in vivo. Specific /sup 125/I-insulin binding to cultured IM-9 human lymphocytes and MCF-7 human breast cancer cells was determined after preincubation with metformin. Specific /sup 125/I-insulin binding to circulating monocytes was also evaluated in six controls, eight obese subjects, and six obese type II diabetic patients before and after a short-term treatment with metformin. Plasma insulin levels and blood glucose were also measured on both occasions. Metformin significantly increased insulin binding in vitro to both IM-9 lymphocytes and MCF-7 cells; the maximum increment was 47.1% and 38.0%, respectively. Metformin treatment significantly increased insulin binding in vivo to monocytes of obese subjects and diabetic patients. Scatchard analysis indicated that the increased binding was mainly due to an increase in receptor capacity. Insulin binding to monocytes of normal controls was unchanged after metformin as were insulin levels in all groups; blood glucose was significantly reduced after metformin only in diabetic patients. These data indicate that metformin increases insulin binding to its receptors in vitro and in vivo. The effect in vivo is observed in obese subjects and in obese type II diabetic patients, paralleling the clinical effectiveness of this antidiabetic agent, and is not due to receptor regulation by circulating insulin, since no variation in insulin levels was recorded.

Research Organization:
Universita di Catania, Ospedale Garibaldi, Italy
OSTI ID:
6223513
Journal Information:
Diabetes Care; (United States), Vol. 7
Country of Publication:
United States
Language:
English

Similar Records

Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor
Journal Article · Fri May 22 00:00:00 EDT 2015 · Biochemical and Biophysical Research Communications · OSTI ID:6223513

Metformin-induced inhibition of the mitochondrial respiratory chain increases FGF21 expression via ATF4 activation
Journal Article · Fri Oct 11 00:00:00 EDT 2013 · Biochemical and Biophysical Research Communications · OSTI ID:6223513

Factors circulating in the blood of type 2 diabetes mellitus patients affect osteoblast maturation – Description of a novel in vitro model
Journal Article · Sun Mar 15 00:00:00 EDT 2015 · Experimental Cell Research · OSTI ID:6223513